DUBLIN, March 03, 2022--(BUSINESS WIRE)--The "Capsule Filling Machine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Manual Capsule Filling Machines, Semi-Automatic Capsule Filling Machines, and Fully Automatic Capsule Filling Machines), Application (Pharmaceutical, Cosmetics, Others), and Capacity" report has been added to ResearchAndMarkets.com's offering.
The capsule filling machine market is projected to reach US$ 290.92 million by 2028 from US$ 211.32 million in 2021; it is estimated to grow at a CAGR of 4.7% during 2021-2028.
The report highlights trends prevailing in the market and factors driving its growth. The growth of the market is attributed to the advancement in capsule filling machine and the rising prevalence of chronic diseases. However, the high cost incurred in capsule filling machine production hampers the market growth.
The global medical device industry is witnessing continuous innovations and technological advancements, which, in turn, drives the healthcare sector worldwide and supports the global capsule filling machine market growth. According to the International Trade Administration (ITA), the US Department of Commerce is the world's largest market for medical devices. Its overall valuation was US$ 156 billion in 2017, which is expected to reach US$ 208 billion by 2023.
Medical device exports from the US exceeded US$ 43 billion in 2018. Globally, the US medical device firms are renowned for their technological advancements and innovative products. In the country, there are over 6,500 medical device companies, most of which are small and medium-sized enterprises (SMEs).
Additionally, Germany is Europe's leading importer and exporter of medical devices, and it manufactures high-quality medical equipment. Almost all leading US firms, such as GE Healthcare, Johnson & Johnson, Becton Dickinson, Abbvie, Stryker, Zimmer, 3M, McKesson, Cardinal Health, Henry Schein, and Medline, have a presence in Germany. The rising markets in the developing countries are presenting lucrative prospects to market participants for the expansion of their firms. Most of the market players are focusing on countries, such as China, India, and the UAE, due to the surging incidence of chronic diseases, expanding use of the latest medical technology in hospitals, and the increasing awareness about sophisticated medical technologies.
The global capsule filling machine market, based on type, is segmented into manual capsule filling machines, semi-automatic capsule filling machines, and fully automatic capsule filling machines. The fully automatic capsule filling machines segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period. By application, the market is segmented into pharmaceutical, cosmetics, and others. In 2021, the pharmaceutical segment held the largest share of the market.
Moreover, the segment is expected to register the highest CAGR of 5.0% during 2021-2028 due to the rising use of capsule filling machine in the pharmaceutical industries for filling the empty capsules as the demand of capsule dosage form. Based on capacity, the market is segmented into small (up to 50,000 capsules), medium (50,000 capsules to 100,000 capsules per hour), and high (more than 100,000 capsules per hour). In 2021, the small (up to 50,000 capsules) segment held the largest share of the market. Moreover, the segment is expected to register the highest CAGR of 5.0% from 2021 to 2028 due to the rising use of small (up to 50,000 capsules) due to its convenience across the world.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Capsule Filling Machine Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Capsule Filling Machine Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Advancement in Capsule filling Machine
High Cost Incurred in Capsule Filling Machine Production
Escalating R&D Investments by Pharmaceutical Companies
Capsugel, Inc (A subsidiary of Lonza Group AG)
Dott. Bonapace & C. srl
Zhejiang Fuchang Machinery Co., Ltd
Beijing Hanlin Hangyu Technology Development Inc.
M2G S.r.l
I.M.A. Industria Macchine Automatiche S.p.A.
For more information about this report visit https://www.researchandmarkets.com/r/c9frkp
View source version on businesswire.com: https://www.businesswire.com/news/home/20220303005509/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Back in 1976, Costco was just starting out and existed as a single location in San Diego, California. Fast forward 45 years later and you've got one of the most epic retail institutions around, with...
One day after Boeing (NYSE: BA) stock bounced higher on news of a big 737 plane sale to the parent company of British Airways and Iberia (the International Consolidated Airlines Group), shares of the airplane-building juggernaut are falling 7.2% as of 1:10 p.m. ET. The reason: Boeing may be encountering turbulence at higher altitudes. Earlier on Thursday, the big news around Boeing was the company's announcement that International Airlines Group has agreed to buy 25 Boeing 737-8-200 aircraft and 25 737 MAX 10 jetliners -- and taken out an option to buy as many as 100 more planes besides.
Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.
In early trading Friday, stock markets attempted to make a comeback and end a down week on an up note. As The Fly reports, Truist has only a neutral rating on each of Royal Caribbean and Norwegian Cruise Line -- and rates Carnival stock an out and out sell.
The Dow Jones reversed higher while the S&P 500 battled out of bear market territory. Tesla stock dived amid reports about CEO Elon Musk.
These companies produce the only thing that matters.
Cathie Wood is a long-time Tesla bull, but the stock isn't the largest holding in Wood's ARK Innovation ETF anymore.
What happened The ride in Ford (NYSE: F) stock wasn't very smooth on Friday. The big American carmaker saw its shares decline by nearly 3% on a day when the S&P 500 index essentially traded sideways. A ruling from a court overseas was the key catalyst in that deceleration.
Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.
Yahoo Finance Live anchors discuss allegations that Elon Musk sexually harassed a flight attendant in 2016.
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.
Unlike traditional bonds, which have been absolutely pummeled this year, Series I savings bonds are far safer—because you’re guaranteed to keep up with inflation and there’s no interest rate risk, meaning they don’t lose value as interest rates rise. If you bought I-bonds in April, you were able to lock in the previous 7.1% interest rate for the next six months. The strategies exploit the large difference in interest rate between I-bonds and other investments.
In this article, we discuss 6 stocks that Warren Buffett is selling in 2022. If you want to see more stocks that the billionaire sold, click Warren Buffett is Selling These 3 Stocks in 2022. Warren Buffett, the chief of Berkshire Hathaway, is perhaps the most renowned financier in the investment world, with decades of […]
Another week of big losses as Wall Street adjusts to a "hard" reality. Tesla broke decisively, but it wasn't alone.
(Bloomberg) -- It’s been hard to watch, impossible to predict and a nightmare to trade. But has the S&P 500’s slide been an unqualified panic to date? By some measures no, and that might bode poorly for equities in the near term. Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesStocks Avert Bear Market, Slide for Seventh Week: Markets WrapApple Shows AR/VR Headset
Moderna (NASDAQ: MRNA) shares have dropped 70% since their record high of more than $450 last August. The second reason has to do with Moderna specifically. The company's only commercialized product right now is the coronavirus vaccine, so investors worry about earnings if vaccine demand drops in a post-pandemic world.
A bear market for the S&P 500? The stage certainly appears to be set for one, as equity benchmarks added to ugly weekly declines on Friday.
Rising interest rates, supply chain constraints and Russia’s invasion of Ukraine are all issues currently plaguing the macro climate. The problem with all three, says Tony Dwyer, Canaccord Chief Market Strategist, is that for each problem there’s “no easy exit strategy.” The tough conditions are likely to persist, then. However, on the plus side, while these issues have sent most corners of the stock market into a tailspin, now investors are presented with stocks for which the term “oversold” re
Companies could be returning trillions to shareholders. Here’s how to accept it.
In this article, we discuss 10 financial stocks that Warren Buffett is buying in 2022. If you want to see more financial stock picks of the billionaire, click Warren Buffett is Buying and Holding These 5 Financial Stocks in 2022. Warren Buffett follows the Benjamin Graham school of thought, picking value plays with prices that […]